FIELD: virology. SUBSTANCE: strain L-16B is cultured at infecting dose 0.5-0.05 TCD50/kl on the supporting Eagle medium or medium 199 in the presence of 3-9 vol.% directively added amino acids from the group of essential amino acids or aminopeptide. The yield of virus on the 1-l flat bottle is 560 ml at titer value 6.5 Ig TCD50/0,5 ml. EFFECT: improved method of cultivation. 5 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
LIVE VACCINE FOR MEASLES PROPHYLAXIS | 1996 |
|
RU2129876C1 |
METHOD OF PREPARING MEASLES VIRUS AND SUPPORTING MEDIUM FOR ITS CULTURING (VARIANTS) | 1996 |
|
RU2129607C1 |
METHOD OF REGENERATION OF VIRUS MEASLES VACCINE STRAIN | 1995 |
|
RU2088662C1 |
METHOD OF OBTAINING LINE ASSOCIATED PAROTITIS-MEASURING VACCINE | 0 |
|
SU604343A1 |
METHOD OF PREPARING ASSOCIATED PAROTITIS MEASLES VACCINE | 0 |
|
SU701147A1 |
METHOD FOR OBTAINING BIVALENT VACCINE AGIANTS MAREK'S DISEASE | 2000 |
|
RU2203681C2 |
METHOD OF LIVE ANTIMEASLES VACCINE PREPARING | 1995 |
|
RU2112545C1 |
LIVE CULTURAL ANTIMEASLES VACCINE | 1998 |
|
RU2144369C1 |
STRAIN OF MEASLES VIRUS "ORLOV-B" FOR VACCINE PREPARING | 1995 |
|
RU2081912C1 |
COMBINED VACCINE FOR THE IMMUNOPROPHYLAXIS OF MEASLES, CONTAGIOUS PAROTITIS AND RUBELLA | 2016 |
|
RU2657801C1 |
Authors
Dates
1996-01-27—Published
1994-07-28—Filed